drugset / Trial / NCT01475643

Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.

NCT01475643

Phase 3 Completed 107 enrolled Bausch & Lomb Incorporated
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to compare the efficacy and safety for the treatment of postoperative inflammation following ocular surgery for childhood cataract.

Timeline

Start
2013-06
Primary completion
2017-06-02
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Loteprednol Etabonate Other / unclassified 0.5 % Topical
Subject Prednisolone Other / unclassified 1 % Topical

Indications